We show that, in contrast to our previously reported data in the substantia nigra , striatal COMT and MAO gene expression is unchanged by sex steroids. We achieved this by gonadectomizing 45-day old male rats (adolescence) and replacing endogenous testosterone with either testosterone (T), DHT or 17β-estradiol (estradiol, E) until 60 days of age (young adults). In the current work, we investigated which molecular indices of dopamine neurotransmission are modulated by testosterone and whether testosterone actions in the adolescent male rat nigrostriatal pathway are driven primarily by androgenic or estrogenic mechanisms. Evidence from adult rodent brain indicates that testosterone can modulate nigrostriatal dopamine. However, supplements that increase acetylcholine release or that stop the breakdown of acetylcholine are thought to increase acetylcholine levels. Cholinesterase inhibitors increase activity at acetylcholine receptors by blocking the breakdown of acetylcholine by the enzyme acetylcholinesterase. The "levator ani" muscle of male rats provides a neuromuscular system in which both the muscle and its motoneurons have high levels of androgen receptors. In conclusion, testosterone plays a role in maintaining healthy brain function by influencing neurotransmitters like acetylcholine. Previously, we found that testosterone increased TH in the adolescent substantia nigra ; and here, we predicted that activation of sex steroid receptors in male adolescence would lead to increased striatal TH protein and dopamine. Further, dopamine turnover was increased in the dorsal striatum following gonadectomy and this was prevented by testosterone replacement. We detected no change in dopamine concentration in the dorsal striatum at 14 days after gonadectomy but an increase in dopamine turnover in response to gonadectomy – thus, our data may reflect a transitionary phase between 4 and 28 days of replacement. Our evidence indicates that testosterone also increases DRD1 and DRD5 (excitatory receptors) in the substantia nigra and DRD5 in the striatum, suggesting more generalized sensitivity to secreted dopamine via testosterone exposure. In support of the preference for testosterone to induce local changes in molecular indices of dopamine signaling, we find that increases in DAT protein are found proximal to the soma, in the substantia nigra and not distal, in the striatum. However, when comparing gonadectomised and intact rats, changes in dopamine breakdown enzyme or transporter mRNAs or proteins (where measured) were not found in the striatum, thus the changes in dopamine turnover after gonadectomy may reflect post-transcriptional or post-translational changes in the activity of these proteins. We provide data to support our hypothesis that testosterone may modulate, via mainly androgen receptor-driven changes, gene expression of multiple molecules involved in the regulation of dopamine within the nigrostriatal pathway in adolescent male rat brain. Could acetylcholine be the root of your mental or physical symptoms? However, more research is needed to fully understand how testosterone impacts Alzheimer’s disease progression. Testosterone levels have been observed to decrease with age, which can contribute to the decline in cognitive functions. However, it also plays a significant role in brain function. Let’s explore how these elements interact and their implications for brain function. An acetylcholine dietary supplement isn’t available. Botulinum toxin — used to treat muscle spasticity, cosmetic wrinkles and migraines — works by preventing acetylcholine release from the end of nerve cells. Cholinesterase inhibitors, including donepezil (Aricept®), rivastigmine (Exelon®) and galantamine (Razadyne®), increase cholinergic transmission by inhibiting cholinesterase at the synapse. In both of these conditions, there’s a severe decrease in the amount of acetylcholine receptor stimulation.
